Form 8-K - Current report:
SEC Accession No. 0001829126-24-001107
Filing Date
2024-02-26
Accepted
2024-02-26 16:05:29
Documents
19
Period of Report
2024-02-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifixinc_8k.htm   iXBRL 8-K 30163
2 EXHIBIT 3.1 zeoscientifixinc_ex3-1.htm EX-3.1 9534
6 GRAPHIC ex3-1_001.jpg GRAPHIC 491815
7 GRAPHIC ex3-1_002.jpg GRAPHIC 893652
8 GRAPHIC ex3-1_003.jpg GRAPHIC 673603
9 GRAPHIC ex3-1_004.jpg GRAPHIC 713339
  Complete submission text file 0001829126-24-001107.txt   3912517

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20240220.xsd EX-101.SCH 2991
4 XBRL LABEL FILE ocel-20240220_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocel-20240220_pre.xml EX-101.PRE 22343
20 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifixinc_8k_htm.xml XML 3400
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 24678668
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)